Harrow Health, Inc., 10% Owner at Eton Pharmaceuticals, Inc. (ETON), sold 1,518,000 shares at $7.00 ($10.6M) on 2021-04-12, disclosed to the SEC on 2021-04-12.
Open-market sale of $10.6M ETON by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.